During the recent session, Chromadex Corp (NASDAQ:CDXC)’s traded shares were 0.47 million, with the beta value of the company hitting 2.06. At the last check today, the stock’s price was $7.18, reflecting an intraday loss of -5.93% or -$0.45. The 52-week high for the CDXC share is $7.85, that puts it down -9.33 from that peak though still a striking 81.62% gain since the share price plummeted to a 52-week low of $1.32. The company’s market capitalization is $548.22M, and the average intraday trading volume over the past 10 days was 1.17 million shares, and the average trade volume was 1.11 million shares over the past three months.
Chromadex Corp (CDXC) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. CDXC has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be 0.02.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Chromadex Corp (NASDAQ:CDXC) trade information
Chromadex Corp (CDXC) registered a -5.93% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -5.93% in intraday trading to $7.18, hitting a weekly high. The stock’s 5-day price performance is 5.24%, and it has moved by 109.25% in 30 days. Based on these gigs, the overall price performance for the year is 394.99%. The short interest in Chromadex Corp (NASDAQ:CDXC) is 2.6 million shares and it means that shorts have 9.98 day(s) to cover.
Chromadex Corp (CDXC) estimates and forecasts
Statistics show that Chromadex Corp has outperformed its competitors in share price, compared to the industry in which it operates. Chromadex Corp (CDXC) shares have gone up 130.04% during the last six months, with a year-to-date growth rate more than the industry average at 157.14% against 17.90. In the rating firms’ projections, revenue will increase 16.00% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 26.52M as predicted by 5 analyst(s). Meanwhile, a consensus of 4 analyst(s) estimates revenue growth to 27.74M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 21.2M and 22.15M respectively. In this case, analysts expect current quarter sales to grow by 25.09% and then jump by 25.23% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 35.83%. While earnings are projected to return 157.14% in 2024.
CDXC Dividends
Chromadex Corp is due to release its next quarterly earnings in December. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Chromadex Corp (NASDAQ:CDXC)’s Major holders
Chromadex Corp insiders own 35.39% of total outstanding shares while institutional holders control 23.87%, with the float percentage being 36.94%. VANGUARD GROUP INC is the largest shareholder of the company, while 126.0 institutions own stock in it. As of 2024-06-30, the company held over 3.39 million shares (or 4.5014% of all shares), a total value of $9.24 million in shares.
The next largest institutional holding, with 3.12 million shares, is of BLACKROCK INC.’s that is approximately 4.1422% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $8.51 million.
Also, the Mutual Funds coming in first place with the largest holdings of Chromadex Corp (CDXC) shares are Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF. Data provided on Jun 30, 2024 indicates that Vanguard Total Stock Market Index Fund owns about 2.2 shares. This amounts to just over 2.88 percent of the company’s overall shares, with a $15.97 million market value. The same data shows that the other fund manager holds slightly less at 1.22, or about 1.60% of the stock, which is worth about $8.9 million.
